CPT code 0714T represents transperineal laser ablation of benign prostatic tissue for enlarged prostate when prostate volume is under 50 mL. The code bundles imaging guidance with the ablation procedure. Nationally, this code is relevant as minimally invasive prostate procedures expand treatment options for lower urinary tract symptoms due to benign prostatic hyperplasia, with implications for ambulatory surgical utilization and payer coverage policies.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical service and typical sites of service, payer coverage landscape, common billing modifiers, and where 0714T sits among related procedural options. The publication summarizes benchmark considerations, coding nuances for transperineal approach and prostate size limitation, and policy developments that may affect claims processing and prior authorization practices.

This summary is intended to orient clinicians, coding professionals, and policy analysts to the primary clinical intent of the code, which patients it applies to, and the billing context stakeholders should consider when managing or reviewing claims for transperineal laser ablation.